In our study, PRDX6 was low expressed in QDLS lung cancer, and have a significant difference between the two syndromes, implying that PRDX6 focused on the influence of invasion ability and phospholipid metabolism homeostasis with “Yin deficiency” in the two groups of lung cancer. The gene discussed is PRDX6; the disease is lung cancer.